Visvakuren Naidoo

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.

Vinh Phu Nguyen, Marvin E Sexton, Zahid Ali Zafar, 2023, The Lancet. Respiratory medicine.

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.

H. Makita, W. Busse, E. Bleecker, 2019, The Lancet. Respiratory medicine.